In preclinical models of NASH-induced HCC, CD8+ T cells accumulate in the liver with phenotypes combined tissue residency (CXCR6) with effector (granzyme) and exhaustion (PD-1). This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.